Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$32.77 - $42.31 $218,510 - $282,123
6,668 New
6,668 $278,000
Q2 2023

Aug 11, 2023

BUY
$24.24 - $40.97 $205,700 - $347,671
8,486 New
8,486 $321,000
Q3 2022

Nov 14, 2022

SELL
$28.74 - $39.9 $21,008 - $29,166
-731 Reduced 7.38%
9,169 $275,000
Q2 2022

Aug 15, 2022

BUY
$35.0 - $43.59 $346,500 - $431,541
9,900 New
9,900 $358,000
Q3 2020

Nov 16, 2020

SELL
$54.41 - $68.2 $245,062 - $307,172
-4,504 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$61.66 - $70.16 $28,425 - $32,343
461 Added 11.4%
4,504 $299,000
Q1 2020

May 15, 2020

BUY
$59.35 - $88.73 $83,980 - $125,552
1,415 Added 53.84%
4,043 $247,000
Q4 2019

Feb 14, 2020

BUY
$74.18 - $97.92 $194,945 - $257,333
2,628 New
2,628 $231,000
Q1 2018

May 15, 2018

SELL
$95.91 - $107.26 $4.67 Million - $5.23 Million
-48,737 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$104.5 - $126.38 $4.03 Million - $4.87 Million
38,542 Added 378.05%
48,737 $5.1 Million
Q3 2017

Nov 14, 2017

BUY
$97.26 - $116.2 $991,565 - $1.18 Million
10,195
10,195 $1.15 Million

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.